Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Inspira Technologies Oxy BHN ( (IINN) ) just unveiled an update.
On February 5, 2025, Inspira Technologies announced the integration of a new oxygenation indicator into its AI-powered HYLA blood sensor, which enhances critical care monitoring by allowing rapid detection of oxygen-related conditions. This advancement positions the HYLA sensor as a significant player in the $2.5 billion point-of-care testing and arterial blood gas analyzer market. Clinical validation is underway at Sheba Medical Center, with preliminary results expected soon. The technology, which uses non-invasive optical sensors and machine-learning algorithms, is anticipated to receive FDA clearance by the second half of 2025, further strengthening Inspira’s market position.
More about Inspira Technologies Oxy BHN
Inspira Technologies is an innovative medical technology company operating in the life support and respiratory treatment industry. The company has developed a breakthrough device known as Augmented Respiration Technology (INSPIRA ART), which aims to revolutionize the $19 billion mechanical ventilation market by providing an alternative treatment option for patients with acute respiratory failure. Their technology includes the HYLA blood sensor, offering real-time continuous blood monitoring to aid physicians in patient care.
YTD Price Performance: -19.62%
Average Trading Volume: 728,559
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $20.6M
See more insights into IINN stock on TipRanks’ Stock Analysis page.
